Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
17.37
0.00 (0.00%)
At close: May 22, 2026, 4:00 PM EDT
17.71
+0.34 (1.96%)
After-hours: May 22, 2026, 6:21 PM EDT
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $2.87 billion as of May 22, 2026. Its market cap has increased by 123.66% in one year.
Market Cap
2.87B
Enterprise Value
2.07B
1-Year Change
123.66%
Ranking
Category
Stock Price
$17.37
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $2.87B, an increase of 263.07%. That is a compound annual growth rate of 25.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 2.87B | -10.84% |
| Dec 31, 2025 | 3.22B | 34.33% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 3.22B |
| Denali Therapeutics | 2.96B |
| Relay Therapeutics | 2.95B |
| Arcus Biosciences | 2.95B |
| Tango Therapeutics | 2.93B |
| Beam Therapeutics | 2.85B |
| Alumis | 2.81B |
| Structure Therapeutics | 2.79B |